Fennec Pharmaceuticals Inc. Common Stock
FENC Real Time Price USDRecent trades of FENC by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by FENC's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Therapeutic uses for sodium thiosulfate formulations Jun. 04, 2024
-
Patent Title: Therapeutic uses for sodium thiosulfate formulations Apr. 23, 2024
-
Patent Title: Anhydrous sodium thiosulfate and formulations thereof Apr. 04, 2023
-
Patent Title: Anhydrous sodium thiosulfate and formulations thereof Nov. 29, 2022
-
Patent Title: Anhydrous sodium thiosulfate and formulations thereof Apr. 05, 2022
-
Patent Title: Anhydrous sodium thiosulfate and formulations thereof Oct. 06, 2020
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of FENC in WallStreetBets Daily Discussion
Recent insights relating to FENC
Recent picks made for FENC stock on CNBC
ETFs with the largest estimated holdings in FENC
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view FENC Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.